• Working with

    passion, integrity,
    & true innovation

  • Developing

    novel, first-in-class therapeutics

  • Targeting

    major unmet medical needs

  • Changing

    the approach to
    treating cancer

       

Imetelstat

First-in-class, first-in-clinic,
telomerase inhibitor

 

Divestiture of
Cell Therapy Programs

Click here for further information

 

Telomerase

Learn about our innovative approach to developing a treatment for cancer

 

Geron News

4.25.2013

Geron Updates Imetelstat Development Strategy, Including Progress of Investigator-Sponsored Study in Myelofibrosis

Read More

4.24.2013

Geron to Present at the Needham Healthcare Conference

Read More

4.22.2013

Geron Announces Conference Call to Discuss First Quarter 2013 Financial Results

Read More

 

Events

5.22.2013

2013 Annual Meeting of Stockholders

Learn more

5.1.2013

Geron at the Needham12th Annual Healthcare Conference

Listen to webcast

Download presentation

4.26.2013

Geron Q1 2013 Earnings Conference Call

Listen to webcast